The Fund aims to achieve medium-term growth by investing in equities within Asian markets outside of Japan (including Australasia).

The Fund’s investment objective is to achieve long term capital growth. The Fund seeks to achieve its objective by investing in a broad range of shares from companies domiciled in developed and developing (emerging market) Asian countries, or from companies which generate a significant amount of their business from these countries.

The Fund’s investment objective is to achieve long term capital appreciation by primarily investing in a diversified portfolio of global equity securities which may be listed or traded on a Regulated Market.

The Fund aims to preserve capital and achieve long-term capital appreciation by investing throughout the biotechnology ecosystem, across geographies and market capitalisations.

The Fund’s investment objective is to achieve long term capital growth. The Fund seeks to achieve its objective by investing in a broad range of shares from companies in The Peoples’ Republic of China, Hong Kong and Taiwan (known as ‘Greater China’), or from companies which generate a significant amount of their business from Greater China.

The Fund’s investment objective is to achieve long term capital growth. The Fund seeks to achieve its objective by investing in a broad range of shares from companies in emerging markets (developing countries), or from companies which generate a significant amount of their business from emerging market countries.

The Fund aims to achieve both income and long term capital growth through a portfolio of emerging market equities.

A specialist small-cap long/short absolute strategy managed by Rob Gurner. Rob joined the firm in 2003 and was responsible for setting up its European small companies’ team while he has been investing on a long/short basis in European small companies since January 1999, when he was a founder employee at Ennismore Fund Management.

The Fund’s investment objective is to deliver strong, long-term risk-adjusted returns to achieve both income and capital growth by investing in companies that are incorporated, headquartered, or exercise a significant part of their economic activities (greater than 20%) in European markets/countries (excluding the United Kingdom).

The Fund aims to provide long-term capital growth by investing primarily in the securities of financial sector companies globally.

The Fund's investment objective is to generate a positive absolute return over rolling 12-month periods, in all market conditions. There is no guarantee the Fund will achieve this objective over any given period.

The Fund’s investment objective is to generate both income and long term capital growth by investing in a diversified portfolio of securities, primarily in the global convertible market.

The Company’s investment objective is to generate for investors a growing dividend income together with capital appreciation.

The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks.

The Fund aims to provide an attractive total return, irrespective of broader economic and financial market conditions, by investing in companies operating within the international insurance sector.

The Fund aims to achieve long-term capital appreciation through investing in a globally-diversified portfolio of technology companies.

The Fund aims to achieve long-term capital appreciation by investing in a globally diversified portfolio of healthcare companies.

The Fund aims to achieve long-term capital growth by investing in a globally diversified portfolio of healthcare companies.

The Fund aims to preserve capital and achieve long-term growth by investing in a globally-diversified portfolio of companies within the healthcare industry.

The Fund aims to provide an attractive level of income for investors, together with capital growth, by investing primarily in the equity, debt and other securities of financial companies worldwide.

The Fund aims to generate long-term capital growth by investing in the shares of Japanese companies, or companies that generate a significant amount of their business in Japan. The Fund will apply a 'value' based stock picking approach, investing in a concentrated portfolio of large, medium and small capitalisation companies.

The Fund aims to achieve long-term capital appreciation by investing in a diversified portfolio of securities of North American companies.

The Company aims to maximise long-term capital growth through investing in a diversified portfolio of technology companies around the world.

The Fund aims to achieve a positive absolute return on a 12-month rolling basis¹ by investing predominantly in UK companies and, to a significantly lesser degree, in European and global equities.

The Fund's objective is to achieve long term capital appreciation by primarily investing in a diversified portfolio of equity securities listed in the UK.